Category : Search result: abdominal obesity


Jaundice with Abdominal Pain: A Warning Sign

Jaundice accompanied by abdominal pain is a critical warning sign of a possible bile duct obstruction. Learn about the causes, symptoms, and urgent need for medical evaluation to prevent serious liver complications.

Weight-Loss Pill Race in 2026: Lilly Leads Novo Nordisk

Novo Nordisk and Eli Lilly to launch oral GLP-1 drugs in 2026. Despite Novo's head start, analysts predict Lilly's market leadership in obesity and diabetes treatments will persist for years. Explore the details.

Bloating vs Belly Fat: Key Differences and Signs

Confused between bloating and belly fat? Learn the 5 simple signs to identify each, understand their distinct causes, and discover the right approach for effective management. Your guide to better gut and body health.

New Obesity Drugs Target Cell Energy Production

Scientists develop novel experimental drugs for obesity by targeting mitochondrial energy production in cells, offering a potential new treatment pathway. Learn about this breakthrough research.

Belly Fat Stiffens Heart, Risk Higher for Men: Study

A new German study reveals belly fat silently alters heart structure, raising heart disease risk, especially in men. A cardiologist explains why waist size, not just weight, is critical for Indians.

GLP-1 Drugs Show Benefits Beyond Weight Loss

New research reveals GLP-1 drugs like semaglutide offer significant heart, liver, and kidney benefits, transforming treatment for obesity-related conditions. Discover the full scope of their impact.

Page 1 of 4